Huntsman-Olin Merger Advances: S-4 Effective, Shareholder Vote Set for August 25
HUN sits 60% above its 52-week low of $7.295.
Summary
The S-4 registration statement for the Huntsman-Olin merger has been declared effective by the SEC, and shareholder votes are set for August 25, 2026. The deal promises over $400 million in synergies and is on track to close in the first half of 2027.
Key Events · M&A and Partnerships · HUN
-
S-4 Registration Effective
The SEC declared the S-4 registration statement effective on July 13, 2026, a key regulatory step enabling the merger to proceed.
-
Shareholder Vote Scheduled
Special meetings for Olin and Huntsman shareholders will be held on August 25, 2026, with a record date of July 9, 2026.
-
Synergy Targets Reaffirmed
The combined company expects over $400 million in cost synergies and integration benefits, with more than $300 million to be achieved within three years post-close.
-
Expected Closing Timeline
The merger is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
Analysis · HUN · Industrial Applications And Services
A major regulatory hurdle for the $12.5 billion all-stock merger of equals between Huntsman and Olin has been cleared, as the SEC declared the S-4 registration statement effective. Special shareholder meetings are now scheduled for August 25, 2026, with a record date of July 9. The filing also includes a supplemental FAQ detailing over $400 million in expected cost synergies and integration benefits, with more than $300 million to be realized within three years. This procedural milestone moves the deal closer to its expected close in the first half of 2027, reducing uncertainty and signaling progress toward creating a vertically integrated chemical giant.
At the time of this filing, HUN was trading at $11.66 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $7.30 to $16.09. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.